Grifols announces positive topline phase 3 fibrinogen clinical trial results
In the AdFIrst study, Biotest's fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired...
Source: businessinsider.com